LyGenesis Raises $19M in Series A-2 Funding Led by Prime Movers Lab
Funds will enable the completion of the ongoing Phase 2a clinical trial growing ectopic livers for patients with end stage liver disease and advance LyGenesis's pipeline of cell therapies ...